CRTH2 antagonist MK-7246: a synthetic evolution from discovery through development

The Journal of Organic Chemistry
Carmela MolinaroPaul O'Shea

Abstract

In this paper, we report the development of different synthetic routes to MK-7246 (1) designed by the Process Chemistry group. The syntheses were initially designed as an enabling tool for Medicinal Chemistry colleagues in order to rapidly explore structure-activity relationships (SAR) and to procure the first milligrams of diverse target molecules for in vitro evaluation. The initial aziridine opening/cyclodehydration strategy was also directly amenable to the first GMP deliveries of MK-7246 (1), streamlining the transition from milligram to kilogram-scale production needed to support early preclinical and clinical evaluation of this compound. Subsequently a more scalable and cost-effective manufacturing route to MK-7246 (1) was engineered. Highlights of the manufacturing route include an Ir-catalyzed intramolecular N-H insertion of sulfoxonium ylide 41 and conversion of ketone 32 to amine 31 in a single step with excellent enantioselectivity through a transaminase process. Reactions such as these illustrate the enabling impact and efficiency gains that innovative developments in chemo- and biocatalysis can have on the synthesis of pharmaceutically relevant target molecules.

References

Apr 8, 1999·British Journal of Pharmacology·L WalchX Norel
Feb 28, 2004·The Journal of Organic Chemistry·Dengjin WangWilliam A Nugent
Jan 25, 2005·Critical Reviews in Immunology·François TrotteinVéronique Angeli
Mar 21, 2006·Trends in Molecular Medicine·Evi Kostenis, Trond Ulven
Jul 14, 2006·Chemical Reviews·Guy R Humphrey, Jeffrey T Kuethe
Feb 6, 2009·Organic & Biomolecular Chemistry·Sandrine Delarue-Cochin, Isabelle McCort-Tranchepain
Jul 22, 2009·Organic Letters·Ian K MangionMark A Huffman
Jul 10, 2010·Expert Opinion on Investigational Drugs·Peter Norman
Nov 26, 2010·Bioorganic & Medicinal Chemistry Letters·Michel GallantZhaoyin Wang
Dec 28, 2010·Bioorganic & Medicinal Chemistry Letters·Daniel SimardJean-François Lévesque
Apr 2, 2011·Biotechnology and Bioengineering·Pär TufvessonJohn M Woodley
Apr 26, 2011·Bioorganic & Medicinal Chemistry Letters·Helmi ZaghdaneMichel Gallant

❮ Previous
Next ❯

Citations

Mar 7, 2013·Current Opinion in Chemical Biology·Gjalt W Huisman, Steven J Collier
Apr 21, 2016·Expert Opinion on Investigational Drugs·Giuseppe SantiniPaolo Montuschi
Apr 23, 2016·The Journal of Organic Chemistry·Alicia M PhelpsShashank Shekhar
Mar 21, 2017·Angewandte Chemie·Janakiram VaitlaKathrin H Hopmann
Jun 17, 2016·Angewandte Chemie·Minqiang Jia, Shengming Ma
Jul 22, 2015·Organic & Biomolecular Chemistry·N RichterH C Hailes
Mar 1, 2014·Chemical Communications : Chem Comm·Nina RichterHelen C Hailes
Jan 15, 2016·Nature·Renyuan Pony YuPaul J Chirik
Apr 15, 2018·Topics in Current Chemistry·James D NeuhausNuno Maulide
Jan 5, 2016·European Journal of Organic Chemistry·Michael FuchsWolfgang Kroutil
Aug 31, 2017·Angewandte Chemie·Manuel BardayChristophe Aïssa
Sep 29, 2018·Angewandte Chemie·James D NeuhausNuno Maulide
Sep 12, 2019·Angewandte Chemie·Daniel ClareChristophe Aïssa
May 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiaohan SongJiang Wang
Jun 30, 2019·Current Diabetes Reports·Olof Eriksson
Oct 22, 2020·Organic & Biomolecular Chemistry·Giorgiana Denisa BisagLuca Bernardi
Apr 25, 2020·Angewandte Chemie·Frank HollmannCaroline E Paul
Dec 11, 2020·Chemical Communications : Chem Comm·Battu HarishSurisetti Suresh
Jul 21, 2020·Journal of Medicinal Chemistry·Thomas ChevietSuzanne Peyrottes
Dec 21, 2018·Organic Letters·Christopher JanotChristophe Aïssa
Dec 19, 2017·Chemical Reviews·Stephen A KellyBrendan F Gilmore
May 20, 2017·ACS Medicinal Chemistry Letters·Matthew D Truppo
Dec 7, 2019·The Journal of Organic Chemistry·Christopher JanotChristophe Aïssa
Mar 27, 2020·The Journal of Organic Chemistry·Yang YuanXiao-Feng Wu
Jun 2, 2020·Organic Letters·Chandrababu Naidu KonaMasahiro Miura
Nov 17, 2021·Angewandte Chemie·Arghya BanerjeeMing-Yu Ngai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.